A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Investigational Site 12199, La Jolla

Investigational Site 12204, Los Angeles

Investigational Site 12201, Englewood

Investigational Site 12196, Washington D.C.

Investigational Site 12207, Chicago

Investigational Site 12202, Baltimore

Investigational Site 12206, Baltimore

Investigational Site 12200, Manhasset

Investigational Site 12203, New York

Investigational Site 12198, Rochester

Investigational Site 12211, Winston-Salem

Investigational Site 12205, Cincinnati

Investigational Site 12209, Pittsburgh

Investigational Site 12208, Salt Lake City

Investigational Site 12210, Richmond

Investigational Site 12197, Kirkland

Investigational Site 78055, Caulfield South

Investigational Site 78056, Kew

Investigational Site 78058, Subiaco

Investigational Site 78057, Westmead

Investigational Site 33021, Innsbruck

Investigational Site 33027, Vienna

Investigational Site 11035, Vancouver

Investigational Site 11037, Ottawa

Investigational Site 11036, Toronto

Investigational Site 39028, Aarhus

Investigational Site 39027, Copenhagen

Investigational Site 35123, Angers

Investigational Site 35122, Créteil

Investigational Site 35125, Lille

Investigational Site 35124, Marseille

Investigational Site 35121, Salouël

Investigational Site 35165, Toulouse

Investigational Site 32408, Berlin

Investigational Site 32410, Bochum

Investigational Site 32409, Münster

Investigational Site 32407, Ulm

Investigational Site 30083, Florence

Investigational Site 30080, Milan

Investigational Site 30082, Napoli

Investigational Site 30081, Pozzilli

Investigational Site 30084, San Giovanni Rotondo

Investigational Site 38059, Leiden

Investigational Site 53150, Gdansk

Investigational Site 53149, Krakow

Investigational Site 53148, Poznan

Investigational Site 53151, Warsaw

Investigational Site 50215, Kazan'

Investigational Site 50213, Moscow

Investigational Site 50214, Nizhny Novgorod

Investigational Site 34058, Birmingham

Investigational Site 34054, Cambridge

Investigational Site 34059, Cardiff

Investigational Site 34056, Headington

Investigational Site 34060, London

Investigational Site 34055, Manchester

Investigational Site 34061, Newcastle upon Tyne

Investigational Site 34057, Sheffield